NCT05010486

Brief Summary

Sexual dysfunction after rectal surgery varies widely in the literature. Prevalence of sexual dysfunction before surgery and desire of patient to treat this condition is also not well established. Objectives of this prospective cohort study were to determine prevalence of sexual dysfunction with a questionnaire before and after surgery. Patient's satisfaction and quality of life were also collected regarding preoperative information given.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2015

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

August 2, 2021

Completed
16 days until next milestone

First Posted

Study publicly available on registry

August 18, 2021

Completed
Last Updated

August 18, 2021

Status Verified

August 1, 2021

Enrollment Period

3.8 years

First QC Date

August 2, 2021

Last Update Submit

August 10, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalence of sexual dysfunction after rectal surgery

    Prevalence of sexual dysfunction will be determined with a validated questionnaire on erectile dysfunction (ED). The International Index of Erectile Dysfunction-5 (IIEF-5) focuses on ED; therefore, it only includes the first 5 questions of the IIEF-15. Each item is scored on a 5-point Likert-type ascending scale with a total score between 1 and 25, where a score of 22 and above corresponds to normal erectile function.

    3 years

Secondary Outcomes (2)

  • Patient satisfaction

    3 years

  • Sexual dysfunction and quality of life

    3 years

Interventions

Eligibility Criteria

Age18 Years - 65 Years
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsgender identity
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Male patients between 18 and 65 years who will have a rectal surgery at the Centre Hospitalier Universitaire de Sherbrooke

You may qualify if:

  • Male between 18 and 65 years old
  • Will undergo one of the following surgeries in the 12 months after the initial visit:
  • Low anterior resection
  • Abdominoperineal resection with end colostomy
  • Total proctocolectomy with ileostomy
  • Total proctocolectomy with ileoanal reservoir
  • Proctectomy
  • Having had a sexual intercourse in the 4 weeks prior to the initial visit
  • Having the desire to maintain sexual activities in the post-operative period

You may not qualify if:

  • Tadalafil allergy/hypersensitivity
  • Having received treatment for erectile dysfunction or medical treatment in the 4 weeks prior to the initial visit
  • Active consumption of nitrate derivatives (NO)
  • History of non-arteritic ischemic optic neuropathy
  • Severe renal or hepatic insufficiency
  • Stroke in the last 6 months
  • Myocardial infarction in the last 3 months
  • Unstable angina pectoris or angina pectoris during sexual relations
  • Cardiac insufficiency Class ≥ 2 in the last 6 months
  • Uncontrolled arrhythmia, hypotension or hypertension

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Sexual Dysfunction, PhysiologicalPatient Satisfaction

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital DiseasesTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Nathalie McFadden, M.D

    Université de Sherbrooke

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 2, 2021

First Posted

August 18, 2021

Study Start

August 1, 2015

Primary Completion

May 1, 2019

Study Completion

May 1, 2019

Last Updated

August 18, 2021

Record last verified: 2021-08